Magnificent Seven Will Have Big 2024 R&D Expenditures
From Nasdaq.: 2024-05-15 09:14:41
Market participants are advised to pay attention to research and development (R&D) efforts of the “Magnificent Seven” companies, as R&D spending plays a crucial role in driving shareholder outcomes and stock performance. Companies like QQQ and QQQM benefit from their strong emphasis on R&D, reinvesting a significant portion of their operating free cash flow back into capex + R&D to enhance their competitive position and long-term growth prospects.
According to McKinsey, organizations expect R&D investments to yield critical technology for developing new products, services, and business models. It is essential for R&D to be integrated centrally into the organization’s mission to deliver genuine value and shape corporate strategy, offering differentiated offerings and strategic options for repositioning the business through new platforms and disruptive breakthroughs.
Goldman Sachs highlights the strong R&D focus of the Magnificent Seven companies, noting that they reinvest a significant portion of their operating free cash flow back into capex + R&D, surpassing the average of companies in the S&P 500. This capital redeployment strategy enhances economic moats and strengthens balance sheets, benefiting long-term investors by driving sustained growth and innovation.
The Magnificent Seven companies are leading in returning capital to shareholders through dividends and buybacks, with tech giants like Alphabet, Meta Platforms, Microsoft, and Apple setting the pace. This commitment to rewarding shareholders, combined with their emphasis on R&D, positions them well for long-term success and solidifies their status as key holdings in ETFs like QQQ and QQQM.
Stay informed on the latest news, information, and analysis in the ETF space by visiting the ETF Education Channel. For more insights on R&D expenditures and investment strategies of the Magnificent Seven companies, read the full article on ETFTrends.com.
Read more at Nasdaq.: Magnificent Seven Will Have Big 2024 R&D Expenditures